Bartalucci, C., Taramasso, L., Ricci, E., De Vito, A., Squillace, N., Ferrara, S., et al. (2024). TD-1 Efficacy, safety and metabolic changes at 6-months after switch to long-acting injectable CAB/RPV: results from an observational prospective multicenter study. In Abstracts from the 16° Italian Conference on AIDS and Antiviral Research (pp.125-127). BMJ Group [10.1136/sextrans-icar-2024.114].

TD-1 Efficacy, safety and metabolic changes at 6-months after switch to long-acting injectable CAB/RPV: results from an observational prospective multicenter study

Bonfanti, P;
2024

abstract + slide
HIV
English
XVI Congresso Nazionale ICAR (Italian Conference on AIDS and Antiviral Research) - 19 al 21 giugno 2024
2024
Abstracts from the 16° Italian Conference on AIDS and Antiviral Research
2024
100
S1
125
127
open
Bartalucci, C., Taramasso, L., Ricci, E., De Vito, A., Squillace, N., Ferrara, S., et al. (2024). TD-1 Efficacy, safety and metabolic changes at 6-months after switch to long-acting injectable CAB/RPV: results from an observational prospective multicenter study. In Abstracts from the 16° Italian Conference on AIDS and Antiviral Research (pp.125-127). BMJ Group [10.1136/sextrans-icar-2024.114].
File in questo prodotto:
File Dimensione Formato  
Bartalucci-2024-Sexually Transmitted Infections-VoR.pdf

accesso aperto

Descrizione: No commercial re-use. See rights and permissions. Published by BMJ.
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Altro
Dimensione 1.81 MB
Formato Adobe PDF
1.81 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/494779
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact